Anti-Human CD134 (OX40) FITC 100 tests
- Known as:
- Antibody toHuman CD134 (OX40) fluorecein 100 tests
- Catalog number:
- 11-1347-42
- Category:
- -
- Supplier:
- eBioscience
- Gene target:
- Anti-Human CD134 (OX40) FITC 100 tests
Ask about this productRelated genes to: Anti-Human CD134 (OX40) FITC 100 tests
- Gene:
- TNFRSF4 NIH gene
- Name:
- TNF receptor superfamily member 4
- Previous symbol:
- TXGP1L
- Synonyms:
- ACT35, OX40, CD134
- Chromosome:
- 1p36.33
- Locus Type:
- gene with protein product
- Date approved:
- 1994-12-15
- Date modifiied:
- 2019-04-23
Related products to: Anti-Human CD134 (OX40) FITC 100 tests
Related articles to: Anti-Human CD134 (OX40) FITC 100 tests
- The etiology of coronary artery Disease (CAD) appears different for men and women, yet insights into underlying sex-specific biological mechanisms are limited. We integrated genomic and proteomic analyses to investigate sex-specific associations of the plasma-proteome with CAD. - Source: PubMed
Publication date: 2026/09/03
Sier Vincent QDimitrova KristinaPeters Erna H A Bvan der Loo Wouter P MWillems van Dijk Kovan Heemst DianaBax Wilhelmina HQuax Paul H APasterkamp GerardMokry MichalJukema J WouterNoordam Raymondde Vries Margreet R - Diet is a modifiable determinant of aging. We develop and validate the Machine-learning YouTHful (MYTH) Diet, a dietary pattern associated with reduced aging-related mortality. Using data from 191,689 participants in the UK Biobank, we conducted a food-wide association analysis and identified 18 food groups significantly associated with aging-related mortality. A Light Gradient Boosting Machine (LightGBM) model was used to rank food importance, leading to the construction of a 10-component MYTH Diet score (range: 0-10). Higher MYTH scores were consistently associated with reduced aging-related mortality in both internal (Quartile 4 vs. 1: hazard ratio [HR] = 0.79; 95% CI: 0.75-0.84) and external (Q4 vs. Q1: HR = 0.68; 95% CI: 0.58-0.80) validation cohorts. Multi-omics analyses revealed that the diet's protective effects were partly mediated through proteomic, metabolic, and inflammatory pathways, with mediators including TNFRSF4, the proportion of polyunsaturated fatty acids (PUFA%), and lipid-related metabolites such as medium very-low-density lipoprotein phospholipids (M-VLDL-PL). Higher MYTH scores were also linked to slower biological aging in the lungs, liver, pancreas, as well as lower risks for 15 aging-related diseases. These findings suggest that the MYTH Diet may offer a biologically informed, scalable framework for developing personalized nutrition strategies aimed at supporting healthy aging and longevity. - Source: PubMed
Publication date: 2026/08/07
Miao YatingLi ZhirongZhang XinyaoLiu ZuyunMa Yanan - - Source: PubMed
Publication date: 2026/08/25
Komatsu-Fujii TakayoshiAsahina RyotaHasegawa TatsuyaNakamizo SatoshiNakajima SaekoKogame ToshiakiKabashima Kenji - The important roles of T cells in tumor progression support the development of a T cell-associated prognostic model for Head and Neck Squamous Cell Carcinoma (HNSCC). - Source: PubMed
Publication date: 2026/08/13
Shi QingmiaoQi ZhenzhenShang BingyangGeng XiaonanZhang ZhiboHuang DiHu Xinjun - The tumor microenvironment, particularly the tumor stroma, plays a critical role in tumor progression, immune evasion, and therapeutic resistance. However, its interaction with the immune landscape in rectal cancer (RC) remains incompletely understood. This study aimed to comprehensively characterize the stromal-immune ecosystem associated with the tumor stroma ratio (TSR) in RC and to evaluate its clinical and therapeutic relevance. - Source: PubMed
Publication date: 2026/08/03
Wang QianyuTian NaGuo HanchuanXiang YingshiXiao YiLin GuoleZhang GuannanXu LaiLu JunyangChen GangCai HuiyunDu XiaohuiDu JunfengWu Bin